161 related articles for article (PubMed ID: 32431693)
1. Production of Autoreactive Heavy Chain-Only Antibodies in Systemic Lupus Erythematosus.
Xu S; Yang H; Zhuo Y; Yu Y; Liao H; Li S; Yue Y; Su K; Zhang Z
Front Immunol; 2020; 11():632. PubMed ID: 32431693
[TBL] [Abstract][Full Text] [Related]
2. Structure of the VH and VL segments of monoreactive and polyreactive IgA autoantibodies to DNA in patients with systemic lupus erythematosus.
Kasaian MT; Ikematsu H; Balow JE; Casali P
J Immunol; 1994 Mar; 152(6):3137-51. PubMed ID: 8144908
[TBL] [Abstract][Full Text] [Related]
3. Human autoantibody recognition of DNA.
Barbas SM; Ditzel HJ; Salonen EM; Yang WP; Silverman GJ; Burton DR
Proc Natl Acad Sci U S A; 1995 Mar; 92(7):2529-33. PubMed ID: 7708679
[TBL] [Abstract][Full Text] [Related]
4. Utilization of the VH4-21 gene segment by anti-DNA antibodies from patients with systemic lupus erythematosus.
Stevenson FK; Longhurst C; Chapman CJ; Ehrenstein M; Spellerberg MB; Hamblin TJ; Ravirajan CT; Latchman D; Isenberg D
J Autoimmun; 1993 Dec; 6(6):809-25. PubMed ID: 8155258
[TBL] [Abstract][Full Text] [Related]
5. The role of somatic hypermutation in the generation of pathogenic antibodies in SLE.
Schroeder K; Herrmann M; Winkler TH
Autoimmunity; 2013 Mar; 46(2):121-7. PubMed ID: 23181829
[TBL] [Abstract][Full Text] [Related]
6. Somatic mutations in the variable regions of a human IgG anti-double-stranded DNA autoantibody suggest a role for antigen in the induction of systemic lupus erythematosus.
van Es JH; Gmelig Meyling FH; van de Akker WR; Aanstoot H; Derksen RH; Logtenberg T
J Exp Med; 1991 Feb; 173(2):461-70. PubMed ID: 1899104
[TBL] [Abstract][Full Text] [Related]
7. Immune tolerance to autoantibody-derived peptides delays development of autoimmunity in murine lupus.
Singh RR; Ebling FM; Sercarz EE; Hahn BH
J Clin Invest; 1995 Dec; 96(6):2990-6. PubMed ID: 8675671
[TBL] [Abstract][Full Text] [Related]
8. Cardiolipin binding a light chain from lupus-prone mice.
Pereira B; Benedict CR; Le A; Shapiro SS; Thiagarajan P
Biochemistry; 1998 Feb; 37(5):1430-7. PubMed ID: 9477972
[TBL] [Abstract][Full Text] [Related]
9. Restricted CDR3 length of the heavy chain is characteristic of six randomly isolated disease-associated VH J558+ IgM autoantibodies in lupus prone motheaten mice.
Lipsanen V; Walter B; Emara M; Siminovitch K; Lam J; Kaushik A
Int Immunol; 1997 May; 9(5):655-64. PubMed ID: 9184911
[TBL] [Abstract][Full Text] [Related]
10. VH4-34 encoded antibody in systemic lupus erythematosus: effect of isotype.
Bhat NM; Lee LM; van Vollenhoven RF; Teng NN; Bieber MM
J Rheumatol; 2002 Oct; 29(10):2114-21. PubMed ID: 12375320
[TBL] [Abstract][Full Text] [Related]
11. A human systemic lupus erythematosus-related anti-cardiolipin/single-stranded DNA autoantibody is encoded by a somatically mutated variant of the developmentally restricted 51P1 VH gene.
Van Es JH; Aanstoot H; Gmelig-Meyling FH; Derksen RH; Logtenberg T
J Immunol; 1992 Sep; 149(6):2234-40. PubMed ID: 1517580
[TBL] [Abstract][Full Text] [Related]
12. Repertoire cloning of lupus anti-DNA autoantibodies.
Roben P; Barbas SM; Sandoval L; Lecerf JM; Stollar BD; Solomon A; Silverman GJ
J Clin Invest; 1996 Dec; 98(12):2827-37. PubMed ID: 8981931
[TBL] [Abstract][Full Text] [Related]
13. Multispecific Antibody Development Platform Based on Human Heavy Chain Antibodies.
Clarke SC; Ma B; Trinklein ND; Schellenberger U; Osborn MJ; Ouisse LH; Boudreau A; Davison LM; Harris KE; Ugamraj HS; Balasubramani A; Dang KH; Jorgensen B; Ogana HAN; Pham DT; Pratap PP; Sankaran P; Anegon I; van Schooten WC; Brüggemann M; Buelow R; Force Aldred S
Front Immunol; 2018; 9():3037. PubMed ID: 30666250
[TBL] [Abstract][Full Text] [Related]
14. Overlap of the anti-cardiolipin and anti-nucleosome responses of the (NZW X BXSB)F1 mouse strain: a new pattern of cross-reactivity for lupus-related autoantibodies.
Gilbert D; Lopez B; Parain J; Koutouzov S; Tron F
Eur J Immunol; 2000 Nov; 30(11):3271-80. PubMed ID: 11093143
[TBL] [Abstract][Full Text] [Related]
15. Anti-dsDNA, anti-nucleosome and anti-C1q antibodies as disease activity markers in patients with systemic lupus erythematosus.
Zivković V; Stanković A; Cvetković T; Mitić B; Kostić S; Nedović J; Stamenković B
Srp Arh Celok Lek; 2014; 142(7-8):431-6. PubMed ID: 25233687
[TBL] [Abstract][Full Text] [Related]
16. Expression of the Fabs of human auto-antibodies in Escherichia coli: optimization and determination of their fine binding characteristics and cross-reactivity.
Kumar S; Kalsi J; Latchman DS; Pearl LH; Isenberg DA
J Mol Biol; 2001 May; 308(3):527-39. PubMed ID: 11327785
[TBL] [Abstract][Full Text] [Related]
17. Precipitating anti-dsDNA peptide repertoires in lupus.
Wang JJ; Colella AD; Beroukas D; Chataway TK; Gordon TP
Clin Exp Immunol; 2018 Dec; 194(3):273-282. PubMed ID: 30086185
[TBL] [Abstract][Full Text] [Related]
18. Variable region genes of human monoclonal autoantibodies to histones H2A and H2B from a systemic lupus erythematosus patient.
Kwon YS; Chung J; Shin GT; Lee SY; Jang YJ
Mol Immunol; 2005 Feb; 42(3):311-7. PubMed ID: 15589319
[TBL] [Abstract][Full Text] [Related]
19. Heavy chain CDR3 optimization of a germline encoded recombinant antibody fragment predisposed to bind the U1A protein.
de Wildt RM; Ruytenbeek R; van Venrooij WJ; Hoet RM
Protein Eng; 1997 Jul; 10(7):835-41. PubMed ID: 9342149
[TBL] [Abstract][Full Text] [Related]
20. Cross-reactivity of human IgG anti-F(ab')2 antibody with DNA and other nuclear antigens.
Williams RC; Malone CC; Cimbalnik K; Presley MA; Roux KH; Strelets L; Silvestris F
Arthritis Rheum; 1997 Jan; 40(1):109-23. PubMed ID: 9008607
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
